| Literature DB >> 23983801 |
Shuo Zhang1, Wei Mu, Lu Xiao, Wen-Ke Zheng, Chun-Xiang Liu, Li Zhang, Hong-Cai Shang.
Abstract
Objective. Despite the systematic literature review of the current evidence, we aim to answer the question " is Deqi an indicator of clinical effects in acupuncture treatment?" Methods. We systematically searched CNKI, VIP, Wanfang Data, PubMed, Embase, and the CENTRAL for three types of study: (1) empirical research probing into the role of Deqi in acupuncture; (2) mechanism studies examining the effect of Deqi on physiological parameters in animal models and human subjects; (3) clinical studies that compared the outcome of acupuncture with Deqi with that of acupuncture without Deqi. Two reviewers independently extracted data, undertook qualitative or quantitative analysis, and summarized findings. Results. The ancient Chinese acupuncturists valued the role of Deqi as a diagnostic tool, a prognosis predictor, and a necessary part of the therapeutic procedure. Findings from modern experimental research provided preliminary evidence for the physiological mechanism that produced Deqi. Few clinical studies generated conflicting evidence of the comparative effectiveness of acupuncture with Deqi versus acupuncture without Deqi for a variety of conditions. Conclusion. The current evidence base is not solid enough to draw any conclusion regarding the predicative value of natural Deqi for clinical efficacy or the therapeutic value of manipulation-facilitated Deqi.Entities:
Year: 2013 PMID: 23983801 PMCID: PMC3747467 DOI: 10.1155/2013/750140
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
A summary of studies on Deqi mechanism in acupuncture.
| Study ID | Acupoints | Instrument | Results |
|---|---|---|---|
| Lin 1991 [ | Acupoints on the human thorax | Voll's electroacupuncture devise and electric resistance tester | The electric resistance at acupoints on the human thorax was not correlated with the existence of Deqi sensations at the same point. |
| Ma 1998 [ | NA | NA | It is hypothesized that activation of the stretch-activated ion channels is a mediator of the Deqi sensation and the transduction of stimulation signals. |
|
Huang et al. 2012 [ | LI3, LI4, LI5, LI11 | Speckle laser blood flow scanner | AWD at LI11 increased microvascular perfusion at 3 meridian acupoints. |
| Watanabe et al. 1994 [ | LI10 | DP1100 system | The latency of the event-related potential triggered triggered by AWD was greater than that by electric stimulation. This showed that AWD may influence CNS functions. |
| Huang 1999 [ | ST36 | EGEG-2DZ | EGG amplitude and the waveform reaction area in two types of Deqi groups differed greatly from those in AOD control. |
| Sandberg et al. 2003 [ | ST36 | PPG | AWD markedly increased muscle and skin blood flow compared with AOD. |
| Zhang et al. 2009 [ | ST36 | CDU | AWD greatly changed hemodynamic parameters of the anterior tibial artery. |
| Yu et al. 2008 [ | ST36, LI11 | CDU | AWD at both points markedly increased the average displacement of the surrounding connective tissues. |
| Karst et al. 2003 [ | LI11 | Flow cytometry | AWD significantly increased the respiratory burst of neutrophils and slightly dropped beta-endorphin levels. |
| Streitberger et al. 2008 [ | LI4 | NA | AWD induced more frequent occurrence of vegetative effects and increased occipital EEG power compared with placebo. |
| Huang et al. 2009 [ | PC6 | PCS | AWD at PC6 markedly increased TCE values measured at a nonacupoint on the meridian. |
| Huang et al. 2010 [ | PC6 | PCS | AWD at PC6 markedly increased TCE values measured at two nonacupoints on the meridian and at PC3. |
| Takamoto et al. 2010[ | # | Functional near-infrared spectroscopy | AWD decreased oxy-Hb concentration in SMA, pre-SMA, and the anterior dorsomedial prefrontal cortex for all stimulated points. |
| Zhang et al. 2011 [ | SJ5 | PET | AWD activated BA7, -13, -20, -22, -39, -42, and -45. |
| Lai et al. 2009 [ | TE5 | PET | AWD markedly activated BA13 and 42 and the left cerebellum compared with sham needling. |
| Chen et al. 2012 [ | TE5 | SPECT | AWD significantly activated BA6, -8, -19, -21, -28, -33, -35, -37, and -47, parahippocampal gyrus, lentiform nucleus, claustrum, and red nucleus, and it deactivated BA9 and -25 compared with sham needling. |
| Pan et al. 2008 [ | SP6 | fMRI | AWD activated the cortex, the subcortical limbic system, the cingulated gyrus, the lentiform nucleus, the corpus albicans, and the inferior semilunar lobule, and it deactivated the anterior central gyrus and the anterior cingulate. |
| Zeng 2009 [ | SJ5 | fMRI | AWD markedly activated BA13, -22, -37, -40, -44, -45, and -47, hippocampus, amygdale, and substantia nigra. |
| Chen et al. 2011 [ | LI4 | fMRI | AWD activated BA4, -6, -9, -13, -17, -18, -19, -21, -22, -23, -29, -30, -35, -36, -37, -39, -40, -41, -42, -43, -44, and -46, and it deactivated medial frontal gyrus, BA24, and the right superior frontal gyrus. |
| Fang et al. 2012 [ | LI4 | fMRI | AWD deactivated the right amygdale, the cingulated gyrus, the midbrain, the medial frontal gyrus, and the cuneus gyrus. |
| Fang et al. 2012 [ | LR3 | fMRI | AWD deactivated the limbic-paralimbic-neocortical network and strengthened the connection of these deactivated brain regions. |
| Tan et al. 2009 [ | ST36 | fMRI | AWD activated functional areas of the cerebral limbic system and dropped serum gastrin levels. |
| Zhang 2011 [ | ST36 | fMRI | AWD activated cerebral areas SI and SII, the left temporal cortex, the insular cortex, the motor, and supplementary motor cortices, the cingulated gyrus, the hypothalamus, and the amygdaloid body. |
| Hu et al. 2012 [ | ST36 | fMRI | AWD deactivated the cerebral limbic system and the functional regions associated with language, cognition, and motor control. |
| Wu et al. 1999 [ | LI4, ST36 | fMRI | AWD at both points activated the hypothalamus and the nucleus accumbens, and it deactivated the rostral part of the anterior cingulate cortex, the amygdala formation, and the hippocampal complex compared with no such effects from AOD. |
| Gong et al. 2003 [ | ST36, ST37 | fMRI | AWD at both points activated bilateral cingulated gyrus, insular lobe, superior wall of lateral sulcus, and precentral gyrus. AOD at both points activated the left posterior central gyrus. Different cerebral areas were activated during Deqi and non-Deqi at the same point. |
| Claunch et al. 2012 [ | LI4, ST36, LR3 | fMRI | AWD at all three points deactivated the right subgenual, the right subgenual cingulate, the right isthmus of the cingulum bundle, and the right BA31. |
| Asghar et al. 2010 [ | LI4 | fMRI | Marked deactivation of the brain area was observed during Deqi in contrast to the occurrence of a mixture of activations and deactivations in the acute pain group. |
| Hui et al. 2005 [ | ST36 | fMRI | Attenuation of signal intensity in the limbic and paralimbic structures of cortical and subcortical regions in telencephalon, the diencephalon, the brainstem, and the cerebellum was observed during AWD compared with signal increase with the acute pain and the AOD group. |
#: acupoints and nonacupoints within the right extensor muscle in the forearm; AOD: acupuncture without Deqi; AWD: acupuncture with Deqi; BA: brodmann area; CDU: color Doppler ultrasound; CNS: central nervous system; EGG: electrogastroenterogram; fMRI: functional magnetic resonance imaging; NA: not available; PCS: percutaneous carbon dioxide sensor; PET: positron emission tomography; PPG: photoplethysmography; SI: secondary somatosensory cortex; SII: primal somatosensory cortex; SMA: supplementary motor area; SPECT: single-photon emission computed tomography; TCE: transcutaneous CO2 emission.
A summary of studies on mechanisms underlying varied Deqi sensations.
| Study ID | Acupoints | Instrument | Results |
|---|---|---|---|
| Bossy et al. 1984 [ | Jing points at the hand | NA | Deqi resulted from correct stimulation of the various structures in relation to an acupoint, such as group II afferent fibers. |
| Wang et al. 1985 [ | PC6, LU11 | NA | Numbness and soreness were conveyed by Group II and Group IV fibers, and heaviness and distention by Group III fibers. |
| Wang and Liu 1989 [ | PC6, PC9, LI1, LU10, LU11 | NA | Needling stimulation primarily activated slowly adapting receptors. The type of receptors varied with the location of acupoints. |
| Kuo et al. 2010 [ | LU5, LU7 | LDF | Strong Deqi sensations, heat and numbness, felt at LU5 were correlated with increased blood flow at LU5. |
| Kuo et al. 2004 [ | SI6, SI8 | LDF | AWD increased blood flow at acupoints. The speedy flowing of tissue fluid along the body stalk may explain the occurrence of propagated sensation along the meridian. |
| Kuo et al. 2004 [ | LI4, LI11 | LDF | Deqi sensations such as soreness, numbness, and heat coexisted with increased blood flow at acupoints. |
| Lee et al. 2010 [ | SP3, KI2 | Ultrasound dopplerography | Deqi-related warm, radiating, and energetic feelings were correlated with decreased blood flow velocity. |
| Zhang et al. 2011 [ | SJ5 | fMRI | Deqi sensations perceived at SJ5 were mainly soreness, numbness, distending, and heaviness, corresponding to activated left temporal lobe and superior temporal gyrus. By contrast, tingling was felt at a neighboring nonacupoint, and the left limbic lobe and hippocampal gyrus were excited. |
Abbreviations: fMRI: functional magnetic resonance imaging; LDF: laser doppler flowmeter; NA: not available.
A summary of mechanism studies on needling intensity and Deqi.
| Study ID | Acupoints | Instrument | Results |
|---|---|---|---|
| Deng and Zhou | ST36 | PowerLab 4/25 | A marked difference was observed in muscular contractility at Deqi depth compared with that at two non-Deqi depths. |
| Choi et al. 2012 [ | SP6, SP9, ST36, GB39 | SASS | Pressure pain threshold and Deqi sensation increased as acupuncture simulation intensified (needling with rotation > deep needling > superficial needling). |
| Park et al. 2011 [ | NA | Ultrasound imaging | Pricking and sharp sensations appeared more frequently when shallower tissues were needled, whereas deep, dull, heavy, spreading, and electric feelings predominated in deeper tissue levels. The introduction of needle rotation in addition to oscillation intensified deep, dull, and heavy rather than pricking and sharp sensations. |
Abbreviations: NA: not available; SASS: subjective acupuncture sensation scale.
Characteristics of the included clinical studies.
| Study ID | Type of disease | Sample (T/C) | Comparison (exposure) | Treatment course | Outcome measures |
|---|---|---|---|---|---|
| Ma 2012 [ | Primary hypertension | 293 totally | Patient-reported natural Deqi after intramuscular needle insertion versus noncharacteristic Deqi sensations | One 30 m session | Blood pressure |
| Mei et al. 2010 [ | Bell's palsy | 28/22 | Intramuscular insertion and manipulation + medication versus nonmanipulation + medication | Five 30 m sessions per week for 4 weeks | Effective rate based on HBS, 16PF, HAMA, and DSS (VAS) |
| Xu et al. 2013 [ | Bell's palsy | 167/171 | Intramuscular insertion and manipulation until Deqi + medication versus nonmanipulation + medication | Five 30 m sessions per week for 4 weeks | Facial-nerve function (HBS), FDI, WHO HR-QoL, DSS (VAS), and adverse events |
| Lund et al. 2006 [ | Pelvic pain in late pregnancy | 35/35 | Intramuscular insertion and manipulation until the patient-reported Deqi versus subcutaneous insertion and nonmanipulation | Two 30 m sessions per week for 5 weeks | Pain intensity (VAS) at rest/during daily activities and NHPQ |
| Haker and Lundeberg 1990 [ | Epicondylalgia | 86 in total | Intramuscular insertion and manipulation until Deqi versus subcutaneous insertion and nonmanipulation | Ten 20 m sessions (2 or 3 times weekly), and followup after 3 and 12 months | Patient-reported pain improvement, lifting test, and vigorimeter test |
| Xiong et al. 2011 [ | Primary dysmenorrhea | 45/45 | Intramuscular insertion (1-2 cm) and manipulation until Deqi versus nonmanipulation | Five consecutive 30 m sessions per menstrual cycle and for 3 courses | Effective rate, pain intensity (VAS), pain duration, and DSS (nervousness using VAS, acupuncture confidence questionnaire, EPQ, and 16PF were added in Xiong et al. 2012 [ |
| Chen 2011 [ | Cervical spondylosis | 36/34 | Intramuscular insertion and manipulation until Deqi + intradermal needle placement versus subcutaneous insertion and nonmanipulation + intradermal needle placement | Ten 20 m sessions, and followup at 1 and 3 months | NPQ, MPQ, and SF-36 |
| Zheng 2012 [ | Migraine | 9/10 (completed) | Intramuscular insertion and manipulation until Deqi versus subcutaneous insertion and nonmanipulation | Twelve 30 m sessions, lasting for 8 weeks. Followup at 1 and 2 months | Migraine assessment tool (self-devised), pain intensity (VAS), pain duration, response rate, and safety |
The latter set of numbers in the “Sample” column refers to the number of participants included in data analysis. Abbreviations. DSS: Deqi sensation scale. It is a tool providing typical descriptors of the needling sensations for patients to choose from those the best that represent their experience. Combining with VAS, it allows rating of the intensity of response to each sensation ranging from “none” to “unbearable pain,” or on a numeric scale. EPQ: eysenck personality questionnaire; FDI: facial disability index; FDIP: FDI physical function scores; HAMA: the Hamilton anxiety scale; HBS: House-Brackmann scale; m: minute; MPQ: the McGill pain questionnaire; NHPQ: the Nottingham health profile questionnaire; NPQ: the Northwick Park questionnaire; 16PF: 16 personality factor questionnaire; VAS: visual analog scale.
Summary of the findings table for the evidence of the predicative value of natural Deqi for clinical efficacy.
| Natural AWD compared with natural AOD for primary hypertension | ||||
|---|---|---|---|---|
| Outcomes | Illustrative comparative risks (95% CI) | No. of participants (studies) | Quality of the evidence (grade) | |
| Natural AOD | Natural AWD | |||
| Blood pressure (SP) | The mean systolic blood pressure in the control groups was 152.225 mmHg | The mean systolic blood pressure in the intervention group was 15.88 mmHg lower (16.34 to 15.42 mmHg lower) | 183 | ⊕⊝⊝ ⊝ |
|
| ||||
| Blood pressure (DP) | The mean diastolic blood pressure in the control groups was 93.093 mmHg | The mean diastolic blood pressure in the intervention group was 6.42 mmHg lower (6.74 to 6.10 mmHg lower) | 183 | ⊕⊝⊝ ⊝ |
1This single cohort study has appropriate eligibility criteria, but it suffers from subjective measurement of exposure (patient-reported Deqi sensation) and very short treatment course (one session and no followup).
2Very narrow CI. Confidence interval < 1/10 effect size.
3A single study is very likely to be biased.
4It was observed that the mean difference of blood pressure was 15.88 lower in AWD group compared with AOD group. The effect size is large.
Summary of the findings table for the evidence of comparative effects of AWD versus AOD for Bell Palsy.
| AWD compared with AOD for Bell Palsy | ||||||
|---|---|---|---|---|---|---|
| Study ID | Outcomes | Illustrative comparative risks (95% CI) | Relative effect (95% CI) | No. of participants (studies) | Quality of the evidence (grade) | |
| AOD (assumed risk) | AWD (corresponding risk) | |||||
|
Mei et al. 2010 [ |
Effective rate (followup: 3 months) | Study population | RR 1.40 (1.00 to 1.97) | 50 (1 study) | ⊕⊝⊝⊝ | |
| 636 per 1000 | 890 per 1000 (636 to 1000) | |||||
|
| ||||||
|
Xu et al 2013 [ |
Complete recovery rate (followup: 6 months) | Study population | RR 1.27 (1.14 to 1.42) | 338 (1 study) |
⊕⊕⊕ ⊕ | |
| 708 per 1000 | 899 per 1000 (807 to 1000) | |||||
1Patient-important outcome.
2Randomization methods and allocation concealment not mentioned. Stratified and randomized assignment and binding of the patient were mentioned. For acupuncture trials, blinding of the practitioner is impossible. None lost to followup. No selective outcome reporting.
3This item was omitted here because we assessed one single study.
4Subjective assessment based on any observed improvement on HB scale for facial nerve function. RR has a wide CI; it almost equals effect size and covers 1.0.
5A single study is very likely to be biased. However, it was omitted here to avoid all evidence being “very low” in quality and therefore indistinguishable.
6Computer-generated random number sequence, randomized assignment, allocation concealment (sealed opaque envelope, and a designated personnel kept it) and blinding of the patient, recruiter, and assessor were described. For acupuncture trials, blinding of the practitioner is impossible; 22/338 dropouts, ITT analysis done. No selective outcome reporting.
7Subjective outcome, but rigorously controlled. Specifically, three skilled experts rated scores according to the House-Brackmann scale. For RR, narrow CI equals 1/10 effect size.
Summary of the findings table for the evidence of comparative effects of AWD versus AOD for pain.
| Acupuncture with Deqi versus acupuncture without Deqi for pain | ||||||
|---|---|---|---|---|---|---|
| Study ID and descriptions | Outcomes | Illustrative comparative risks (95% CI) | Relative effect (95% CI) | No. of participants (studies) | Quality of the evidence (grade) | |
| AOD (assumed risk) | AWD (corresponding risk) | |||||
|
Lund et al. 2006 [ | Effective rate for change in morning pain intensity after treatment assessed with change in VAS scores, grouped into “lower,” “unchanged,” and “higher” | Study population | RR 0.99 (0.69 to 1.41) | 47 (1 study) |
⊕⊕⊝⊝ | |
| 727 per 1000 | 720 per 1000 (502 to 1000) | |||||
| Effective rate for change in evening pain intensity after treatment assessed with change in VAS scores, grouped into “lower,” “unchanged,” and “higher” | Study population | RR 1.06 (0.73 to 1.54) | 47 (1 study) | ⊕⊕⊝⊝ | ||
| 682 per 1000 | 723 per 1000 (498 to 1000) | |||||
|
| ||||||
|
Haker and Lundeberg 1990 [ | Effective rate for patient reported recovery after treatment assessed with a scale from “unchanged”/“worse” to “excellent” recovery | Study population | RR 1.35 (1.05 to 1.73) | 82 (1 study) |
⊕⊕⊝⊝ | |
| 658 per 1000 | 888 per 1000 (691 to 1000) | |||||
|
| ||||||
|
Xiong et al. 2011 [ | Effective rate for pain relief after treatment assessed with the efficacy assessment guideline for TCM for primary dysmenorrhea | Study population | RR 2.24 (1.51 to 3.32) | 90 (1 study) |
⊕⊕⊕⊝ | |
| 378 per 1000 | 847 per 1000 (571 to 1000) | |||||
| Pain intensity after treatment assessed with VAS, scale from 0 to 10 | The mean pain intensity score in the control group was 4.48 | The mean pain intensity score in the intervention group was 2.78 lower (3.61 to 1.95 lower) | 90 (1 study) | ⊕⊕⊕⊝ | ||
|
| ||||||
| Chen et al. 2011 [ | Neck pain after treatment assessed with the Northwick Park questionnaire, scale from 0 to 100 | The mean neck pain score in the control group was 23.56 | The mean neck pain score in the intervention group was 17.86 lower (23.65 to 12.07 lower) | 70 (1 study) | ⊕⊕⊝⊝ | |
| Pain after treatment assessed with the McGill pain questionnaire, scale from 0 to 60 | The mean pain score in the control group was 20.35 | The mean pain score in the intervention group was 7.80 lower (10.3 to 5.3 lower) | 70 (1 study) | ⊕⊕⊝⊝ | ||
|
| ||||||
| Zheng 2012 [ | Total migraine hours per 4 weeks after treatment | The mean total migraine hours per 4 weeks in the control group were 21.95 hours | The mean total migraine hours per 4 weeks in the intervention group were 19.33 hours longer (9.19 to 29.47 hours longer) | 19 (1 study) | ⊕⊝⊝⊝ | |
| Migraine pain intensity (total VAS score per 4 weeks) after treatment assessed with VAS, scale from 0 to 10 | The mean migraine pain intensity score in the control group was 11.70 | The mean migraine pain intensity score in the intervention group was 7.01 higher (2.8 to 11.22 higher) | 19 (1 study) | ⊕⊝⊝⊝ | ||
1Randomization method and blinding of the patient not mentioned. Randomized assignment, binding of outcome assessor, and allocation concealment mentioned. For acupuncture trials, blinding of the practitioner is impossible; 3/70 patients were lost to followup; reasons explained; no ITT analysis. No selective outcome reporting.
2This item was omitted here because we assessed one single study.
3For this single study, findings presented evident individual variations in both groups. The calculated CI equals 1/3–1/2 effect size.
4A single study is very likely to be biased. However, it was omitted here to avoid all evidence being “very low” in quality and therefore indistinguishable.
5Patient-important outcome.
6Randomization methods, allocation concealment, and blinding of the patient not mentioned. Randomized assignment and binding of outcome assessor mentioned. For acupuncture trials, blinding of the practitioner is impossible; 4/86 patients were lost to followup; reasons explained; no ITT analysis. No selective outcome reporting.
7Subjective assessments. The calculated CI equals 1/9–2/3 effect size.
8Random number table, randomized assignment, allocation concealment, and blinding of the patient and assessor described. For acupuncture trials, blinding of the practitioner is impossible. No dropouts. No selective outcome reporting.
9Central randomization, randomized assignment, and the use of sealed envelope described. Placebo acupuncture was used, and the patient was blinded. However, blinding of the outcome assessor was not mentioned. For acupuncture trials, blinding of the practitioner is impossible. It is highly suspected that the physicians act as assessors; hence, the risk for measurement bias is high. No dropouts. No selective outcome reporting. Imbalanced baseline was reported.
10Central and block randomization and allocation concealment described. The outcome assessor was blinded, but both the patient and the acupuncturist were aware of the allocation. For acupuncture trials, blinding of the practitioner is impossible. High dropout rate (22/59); reasons explained. No selective outcome reporting.
11The trial is ongoing by the time of publication. Preliminary results were published (19/48 cases planned), with high risk of biases.